CT Imaging Biomarkers Predict Clinical Outcomes After Pancreatic Cancer Surgery
نویسندگان
چکیده
This study aimed to determine whether changes in contrast-enhanced computed tomography (CT) parameters could predict postsurgery overall and progression-free survival (PFS) in pancreatic cancer patients. Seventy-nine patients with a final pathological diagnosis of pancreatic adenocarcinoma were included in this study from June 2008 to August 2012. Dynamic contrast-enhanced (DCE) CT of tumors was obtained before curative-intent surgery. Absolute enhancement change (AEC) and relative enhancement change (REC) were evaluated on DCE-CT. PFS and overall survival (OS) were compared based on CT enhancement patterns. The markers of fibrogenic alpha-smooth muscle antigen (α-SMA) and periostin in tumor specimens were evaluated by immunohistochemical staining. The χ test was performed to determine whether CT enhancement patterns were associated with α-SMA-periostin expression levels (recorded as positive or negative). Lower REC (<0.9) was associated with shorter PFS (HR 0.51, 95% CI: 0.31-0.89) and OS (HR 0.44, 95% CI: 0.25-0.78). The α-SMA and periostin expression level were negatively correlated with REC (both P = 0). Among several CT enhancement parameters, REC was the best predictor of patient postsurgery survival. Low REC was associated with a short progression-free time and poor survival. The pathological studies suggested that REC might be a reflection of cancer fibrogenic potential.
منابع مشابه
nanoknife ablation in retroperitoneal tumor
Objective: This present study was aimed to assess the effectiveness and reliability of CT-guided nanoknife ablation in retroperitoneal tumor treatment. Methods: 2 retroperitoneal tumor patients were selected, including one pancreatic cancer patient and one colorectal cancer retroperitoneal metastatic tumor patient. The surgery was performed under general anesthesia with large aperture multi-sli...
متن کاملTreatment of Pancreatic Cancer: What Can We Really Predict Today?
Managing pancreatic cancer remains a big challenge due to its worse course and prognosis. However, therapeutic options and multimodal strategies are increasing nowadays, including new agents, new regimens and chemoradiation. Recently, the FOLFIRINOX regimen has been reported to be more active than gemcitabine in selected metastatic patients. In this setting, it will be of utmost interest to gui...
متن کاملAccuracy of CA 19-9 and radiologic imaging in detecting recurrence after resection for pancreatic cancer.
among all gastrointestinal neoplasms, pancreatic cancer still remains difficult to treat. Resection, with or without adjuvant or neoadjuvant therapy, offers the only chance of long-term survival, although the percentage of patients cured of this disease is very small. Most patients’ tumor recur within two years of surgery, and the pattern of recurrence is well known. Treatment of recurrent panc...
متن کاملClinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours
Objective(s): The objective of this study was to evaluate the performance and utility of 99mTc HYNIC-TOC planar scintigraphy and SPECT/CT in the diagnosis, staging and management of gastroenteropancreatic neuroendocrine tumors (GPNETs). Methods: 22 patients (median age, 46 years) with histologically proven gastroentero-pancreatic NETs underwent 99mTc HYNIC-TOC whole body scintigraphy and regi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 95 شماره
صفحات -
تاریخ انتشار 2016